Olivier Christophe: Colocalization of Factor X with Amyloid Light-Chain Deposits
Olivier Christophe, Director of Research at Inserm, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Haematologica, adding:
“I’m pleased to share our new publication in Haematologica:
‘Factor X colocalizes with amyloid light chain deposits in AL amyloidosis: evidence from three patients’
In this study, we provide immunofluorescence evidence showing colocalization of factor X with amyloid light-chain deposits in tissues from patients with AL amyloidosis, supporting the concept of direct FX sequestration by amyloid deposits.
Importantly, FX deposition was observed even in one patient with normal circulating FX activity, raising interesting questions about the potential role of FX as a biomarker of residual amyloid burden and organ recovery.
We hope this work will encourage clinicians to systematically monitor FX levels in patients with AL amyloidosis.
Indeed, FX monitoring during treatment may provide complementary prognostic information, help assess bleeding risk — particularly before invasive procedures — and better reflect the persistence of residual amyloid deposits beyond hematologic remission.
This work formed an important part of the thesis of Sénadé Atsou and is dedicated to the memory of Frank Bridoux, whose vision and commitment to amyloidosis research made this work possible.
Many thanks to all co-authors from HITh lab Inserm and collaborators from CHU de Poitiers who contributed to this multidisciplinary effort.”
Title: Factor X colocalizes with amyloid light chain deposits in AL amyloidosis: evidence from three patients
Authors: Sénadé Atsou, Alexia Rinsant, Caterina Casari, Peter J Lenting, Vincent Javaugue, Estelle Desport, Laurent Macchi, Cécile V. Denis, Frank Bridoux, Olivier D. Christophe
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 2, 2026, 19:40Minoo Ahmadinejad: Improving the Recognition of Women and Girls With Hemophilia
-
Jul 2, 2026, 19:26Dhinesh Selvaraju: FDA Expands Access to HYMPAVZI in Hemophilia
-
Jul 2, 2026, 19:13Syed Fahad Hussain: Not Every Low Platelet Count Tells the Same Story
-
Jul 2, 2026, 18:59Indu Thakur: Supporting Blood Donation Through Public Awareness in MSBT
-
Jul 2, 2026, 18:47Vee Townsend: IMHUE Highlights 9 Myths and Facts About Hemophilia B
-
Jul 2, 2026, 17:17Nico Gagelmann: Launching Myths and Facts on Hematology and Cell Therapy
-
Jul 2, 2026, 17:05Haroun Gajraj: Understanding the Technology Behind Spider Vein Treatment
-
Jul 2, 2026, 16:44Ney Carter Borges: Is It Time to Personalize Antiplatelet Therapy?
-
Jul 2, 2026, 16:22Introducing a New Resource for the ITP Community – ITP Support Association